Open access
17 December 2015

Genome Sequence of Acinetobacter baumannii Strain D36, an Antibiotic-Resistant Isolate from Lineage 2 of Global Clone 1


Multiply antibiotic-resistant Acinetobacter baumannii isolate D36 was recovered in Australia in 2008 and belongs to a distinct lineage of global clone 1 (GC1). Here, we present the complete 4.13 Mbp genome sequence (chromosome plus 4 plasmids), generated via long read sequencing (PacBio).


Acinetobacter baumannii isolate D36 was isolated from a soldier in 2008 at North Shore Private Hospital, Sydney, Australia (1). It is resistant to several antibiotics, imipenem and meropenem, ceftazidime and cefotaxime, fluoroquinolones, sulfonamides, and aminoglycosides gentamicin, kanamycin, tobramycin, and neomycin (2). It was previously shown to represent a distinct lineage of global clone 1 (GC1) having AbaR4 rather than an AbaR0 derivative in the comM gene (1).
DNA was subjected to sequencing on 2 PacBio single-molecule real-time (SMRT) cells (chemistry version C2-P4) at DNA Link (South Korea). A total of 113,387 reads were obtained with an average length of 7,984 bp and average quality 0.827. The PacBio reads were assembled de novo using SMRT Analysis Suite v2.3.0 and the HGAP.3 algorithm with default parameters.
The assembled contiguous chromosomal sequence was 4,063,596 bp and a segment of 51.7 kb between two copies of the rRNA genes on either side of the replication origin is inverted relative to other A. baumannii genomes. Plasmid contigs were circularized using PCR, producing four plasmids pD36-1 to pD36-4 of 4,754 bp, 6,078 bp, 9,276 bp, and 47,457 bp, respectively. Protein coding rRNA and tRNA genes were annotated using RAST (3), and the antibiotic resistance and polysaccharide biosynthesis loci, transposons, insertion sequences, phage genomes, and plasmids were annotated manually.
The genome sequence confirms that D36 is a member of global clone 1 (GC1), one of the resistant clones found on all inhabited continents. It belongs to CC1 (ST81) in the Institute Pasteur MLST scheme (4). In the Oxford scheme (5) it is ST498(ST247), a single locus variant of ST231(ST109) differing only in gpi which resides in the capsule locus, and D36 carries the KL12 capsule locus (6, 7) and the OCL1 outer core locus (8). A 49.9-kb transposon, designated Tn6171, carries a potential siderophore synthesis gene cluster previously seen only in ATCC 17978 (9). Tn6171 encodes transposition proteins related to those of Tn7. The chromosome includes 18 copies of the insertion sequence (IS) ISAba1, three of ISAba14 and one each of ISAba12 and IS26. Three potential integrated phage genomes of 95,928 bp, 36,399 bp, and 36, 438 bp were also identified using PHAST (10).
Carbapenem resistance is due to the presence of the oxa23 gene in AbaR4 in comM (1) and third generation cephalosporin resistance is due to increased transcription of the ampC gene from an upstream ISAba1 (11). The 6,078-bp plasmid pD36-2 is pRAY* carrying the aadB gentamicin, kanamycin, and tobramycin resistance gene cassette (2). Plasmid pD36-4 carries the sul2 sulfonamide resistance gene, the aphA1a kanamycin/neomycin resistance gene in Tn4352, a mer module conferring resistance to mercuric ions, and 11 IS. pD36-1 and pD36-3 are cryptic.
The genome sequence of D36 will underpin studies of the evolution of the second branch of the GC1 clonal complex.

Nucleotide sequence accession numbers.

The complete genome sequence has been deposited in DDBJ/ENA/GenBank under the accession numbers CP012952 (chromosome) and CP012953 to CP012956 (plasmids). The versions described in this paper are the first versions, CP012952.1 to CP012956.1.


This work was supported by the NHMRC of Australia (project grant 1026189 to R.M.H. and fellowship 1061409 to K.E.H.), and the Victorian Life Sciences Computation Initiative (VLSCI) (VR0082).
We thank Clarence Fernandez for supplying isolate D36.


Hamidian M, Hall RM. 2011. AbaR4 replaces AbaR3 in a carbapenem-resistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital. J Antimicrob Chemother 66:2484–2491.
Hamidian M, Nigro SJ, Hall RM. 2012. Variants of the gentamicin and tobramycin resistance plasmid pRAY are widely distributed in Acinetobacter. J Antimicrob Chemother 67:2833–2836.
Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, Edwards RA, Gerdes S, Parrello B, Shukla M, Vonstein V, Wattam AR, Xia F, Stevens R. 2014. The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res 42:D206–D214.
Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5:e10034.
Bartual SG, Seifert H, Hippler C, Luzon MAD, Wisplinghoff H, Rodríguez-Valera F. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43:4382–4390.
Kenyon JJ, Marzaioli AM, Hall RM, De Castro C. 2015. Structure of the K12 capsule containing 5,7-di-N-acetylacinetaminic acid from Acinetobacter baumannii isolate D36. Glycobiology 25:881–887.
Kenyon JJ, Marzaioli AM, De Castro C, Hall RM. 2015. 5,7-di-N-acetyl-acinetaminic acid: A novel non-2-ulosonic acid found in the capsule of an Acinetobacter baumannii isolate. Glycobiology 25:644–654.
Kenyon JJ, Hall RM. 2013. Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes. PloS One 8:e62160.
Eijkelkamp BA, Hassan KA, Paulsen IT, Brown MH. 2011. Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions. BMC Genomics 12:126.
Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DS. 2011. PHAST: a fast phage search tool. Nucleic Acids Res 39:W347–W352.
Hamidian M, Hall RM. 2014. Tn6168, a transposon carrying an ISAba1-activated ampC gene and conferring cephalosporin resistance in Acinetobacter baumannii. J Antimicrob Chemother 69:77–80.

Information & Contributors


Published In

cover image Genome Announcements
Genome Announcements
Volume 3Number 631 December 2015
eLocator: 10.1128/genomea.01478-15


Received: 26 October 2015
Accepted: 27 October 2015
Published online: 17 December 2015



Mohammad Hamidian
School of Molecular Bioscience, The University of Sydney, Sydney, Australia
Jane Hawkey
Department of Biochemistry and Molecular Biology and Centre for Systems Genomics, University of Melbourne, Melbourne, Australia
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Australia
Department of Biochemistry and Molecular Biology and Centre for Systems Genomics, University of Melbourne, Melbourne, Australia
Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Australia
Ruth M. Hall
School of Molecular Bioscience, The University of Sydney, Sydney, Australia


Address correspondence to Ruth M. Hall, [email protected].

Metrics & Citations


Note: There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.

Citation counts come from the Crossref Cited by service.


If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

View Options

Figures and Media






Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy